Evidence map›Paper›PMID 40745106›Full record

ArticlePlant molecular biology2025

Genomic language models with k-mer tokenization strategies for plant genome annotation and regulatory element strength prediction.

Shosuke Suzuki, Kazumasa Horie, Toshiyuki Amagasa, Naoya Fukuda

Abstract read
In one paragraph

Article in Plant molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shosuke SuzukiFaculty of Life and Environmental Sciences Tsukuba-Plant Innovation Research Center, University of Tsukuba, Tsukuba, Japan.ORCID http://orcid.org/0009-0001-3354-195X
Kazumasa HorieCenter for Computational Sciences, University of Tsukuba, Tsukuba, Japan. horie@bipl-sdnn.org.
Toshiyuki AmagasaCenter for Computational Sciences, University of Tsukuba, Tsukuba, Japan.
Naoya FukudaFaculty of Life and Environmental Sciences Tsukuba-Plant Innovation Research Center, University of Tsukuba, Tsukuba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in genomic language models have improved the accuracy of in silico analyses, yet many rely on resource-intensive architectures. In this study, we focus on the impact of k-mer tokenization strategies-specifically varying window sizes (three to eight) and overlap schemes-on the performance of transformer-based genomic language models. Through extensive evaluation across multiple plant genomic tasks, including splice site and alternative polyadenylation site prediction, we show that thoughtful design of the k-mer tokenizer plays a critical role in model performance, often outweighing model scale. In particular, overlap-based tokenization generally enhances performance by preserving local sequence context, while certain non-overlap configurations achieve competitive accuracy with improved computational efficiency in some tasks. Despite using a smaller model, our approach performs on par with the state-of-the-art AgroNT model in many cases. These results emphasize that k-mer tokenization, not merely model size, is a key determinant of success in genomic sequence modeling. Our findings provide practical guidance for designing efficient genomic language models tailored to plant biology.

Indexed as

Genome, PlantGenomicsModels, GeneticMolecular Sequence AnnotationRegulatory Sequences, Nucleic AcidComputational BiologyComputer SimulationDnaGenome annotationGenomic language modelk-merTransformer

Identifiers

PMID40745106
PMCPMC12313756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.